Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: Trophic and tropic effects in a rodent model of huntington's disease

Journal of Comparative Neurology

Volumn 387, Issue 1, 1997, Pages 96-113

  Kordower, Jeffrey H ^a   Chen, Er Yun ^a   Winkler, Christian ^b   Fricker, Rose ^b   Charles, Vinod ^a   Messing, Albee ^c   Mufson, Elliott J ^a   Wong, Shou C ^d   Rosenstein, Jeffrey M ^e   Björklund, Anders ^b   Emerich, Dwaine F ^d   Hammang, Joseph ^d   Carpenter, Melissa K ^d  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d CytoTherapeutics Inc   (United States)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Choline acetyltransferase; GABA; Immunohistochemistry; NADPH diaphorase; Striatum

Indexed keywords

CHOLINE ACETYLTRANSFERASE; EPIDERMAL GROWTH FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE; NERVE GROWTH FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL; TRANSGENIC MOUSE;

ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; CELL LINE; DISEASE MODELS, ANIMAL; EPIDERMAL GROWTH FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HUNTINGTON DISEASE; MALE; MICE; MICE, TRANSGENIC; NERVE GROWTH FACTORS; PC12 CELLS; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION;

EID: 0030885063     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19971013)387:1<96::AID-CNE8>3.0.CO;2-I     Document Type: Article

References (47)

1. Beal, M.F., M.F. Mazurkek, D.W. Ellison, K.J. Swartz, U. McGarvey, E.D. Bird, and J.B. Martin (1988) Somatostatin and neuropeptide Y concentration in pathologically graded cases of Huntington's disease. Ann. Neurol. 23:562-569.
2. Bird, E.D. (1980) Chemical pathology of Huntington's disease. Annu. Rev. Pharmacol. Toxicol. 20:533-551.
3. Bird, E.D., and L.L. Iversen (1974) Huntington's chorea: Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain 97:457-472.
4. Bartus, R.T., R.L. Dean, S. Abelleira, V. Charles, and J.H. Kordower (1996) Lack of immunoreactivity in adult rat striatum following physical trauma, excitotoxicity, and NGF administration. Restor. Neurol. Neurosci. 10:49-59.
5. Brustle, D., and R.D.G. McKay (1996) Neuronal progenitors as tools for cell replacement in the nervous system. Curr. Opin. Neurobiol. 6:688-695.
6. Carpenter, M.K., C. Winkler, R. Fricker, S.C. Wong, C. Greco, D. Emerich, E.-Y. Chen, Y. Chu, J.H. Kordower, A. Messing, A. Björklund, and J.P. Hammang (1996) Transplantation of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice attenuates excitotoxic striatal lesions. Soc. Neurosci. Abstr. 22:577.
7. Charles, V., E.J. Mufson, P.M. Friden, R.T. Bartus, and J.H. Kordower (1996) Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate. Brain Res. 728:193-203.
8. Chen, E.-Y., E.J. Mufson, and J.H. Kordower (1996) Development of trk and p75 NGF receptors in the human brain. J. Comp. Neurol. 369:591-618.
9. Cheng, B., and M.P. Mattson (1992) Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: Prevention by NGF and βFGF. Exp. Neurol. 117:114-123.
10. Cheng, B., D.G. McMahan, and M.P. Mattson (1993) Modulation of calcium current, intracellular calcium levels and cell survival by glucose deprivation and growth factors in hippocampal neurons. Brain Res. 607:275-285.
11. Davies, S.W., and K. Beardsall (1992) Nerve growth factor selectively prevents excitotoxin induced degeneration of striatal cholinergic neurons. Neurosci. Lett. 140:161-164.
12. Emerich, D.F., J.P. Hammang, E.R. Baetge, and S.R. Winn (1994) Implantation of polymer-encapsulated human nerve growth factor secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exp. Neurol. 130:141-150.
13. Emerich, D.F., M.D. Lidner, S.R. Winn, E.-R. Chen, and J.H. Kordower (1996) Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's Disease. J. Neurosci. 16:5168-5181.
14. Ferrante, R.J., N.W. Kowall, M.F. Beal, E.F. Richardson, and J.B. Martin (1985) Selective sparing of a class of striatal neurons in Huntington's disease. Science 230:561-563.
15. Ferrante, R.J., M.F. Beal, N.W. Kowall, E.F. Richardson, and J.B. Martin (1987) Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Res. 411:162-166.
16. Frim, D.M., M.P. Short, W.S. Rosenberg, J. Simpson, X.O. Breakefield, and O. Isacson (1993) Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum. J. Neurosurg. 78:267-273.
17. Frim, D.M., W.M. Yee, and O. Isacson (1993) NGF reduces striatal excitotoxic neuronal loss without affecting concurrent neuronal stress. Neuroreport 4:655-658.
18. Frim, D.M., T.A. Uhler, M.P. Short, Z.D. Ezzedine, M. Klagsbrun, X.O. Breakefield, and O. Isacson (1993) Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. J. Neurosci. Res. 35:452-458.
19. Frim, D.M., U. Wullner, M.R. Bear, and O. Isacson (1994) Implanted NGF-producing fibroblasts induce catalase and ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum. Exp. Neurol. 128:172-180.
20. Gage, F.H., P. Batchelor, K.S. Chen, D. Chin, G.A. Higgins, S. Koh, S. Deputy, M.B. Rosenberg, W. Fischer, and A. Bjorklund (1989) NGF receptor reexpression and NGF-mediated cholinergic neuronal hypertrophy in the damaged adult neostriatum Neuron 2:1177-1184.
21. Gage, F.H., J. Ray, and L.J. Fisher (1995) Isolation, characterization, and use of stem cells from the CNS. Annu. Rev. Neurosci. 18:159-192.
22. Graveland, G.A., R.S. Williams, and M. DiFiglia (1985) Evidence of degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 227:770-773.
23. Greenamyer, J.T., and I. Shoulson (1994) Huntington's disease. In D. Calne (ed): Neurodegenerative Diseases. Philadelphia, PA: Saunders Press, Inc., pp. 685-704.
24. Gusella, J.F., N.S. Wexler, P.M. Conneally, S.L. Naylor, M.A. Anderson, R.E. Tanzi, A.B. Young, I. Shoulson, E. Bonnilla, and J.B. Martin (1983) A polymorphic marker genetically linked to Huntington's disease. Nature 506:234-236.
25. Hanley, T., and J.P. Merlie (1991) Transgene detection in unpurified mouse tail DNA by polymerase chain reaction. Biotechniques 10:56-65.
26. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-978.
27. Hsu, S.M., L. Raine, and H. Fanger (1981) Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:577-580.
28. Junier, M.P., F. Suzuki, B. Onteniente, and M. Peschanski (1994) Target-deprived CNS neurons express the NGF gene while reactive glia around their axonal terminals contain low and high affinity NGF receptors. Mol. Brain Res. 24:247-260.
29. Kordower, J.H., R.T. Bartus, M. Bothwell, G. Schatteman, and D.M. Gash (1988) Nerve growth factor receptor immunoreactivity in the non-human primate (Cebus apella). Morphology, distribution and colocalization with cholinergic enzymes. J. Comp. Neurol. 277:465-486.
30. Kordower, J.H., V. Charles, R. Bayer, R.T. Bartus, S. Putney, L. Walus, and P.M. Friden (1994) Intravenous administration of an NGF conjugate prevents neuronal degeneration in a model of Huntington's disease. Proc. Natl. Acad. Sci. USA 19:9077-9080.
31. Kordower, J.H., E.-Y. Chen, E.J, Mufson, S.R. Winn, and D.F. Emerich (1996) Intrastriatal grafts of polymer encapsulated cells genetically modified to secrete human NGF influence cholinergic and noncholinergic striatal neurons. Neuroscience 72:63-77.
32. Kowall, N.W., R.J. Ferrante, and J.B. Martin (1987) Pattern of cell loss in Huntington's disease. Trends Neurosci. 10:24-29.
33. Maniatis, G.M. (1982) Erythropoiesis: A model for differentiation. Prog. Clin. Biol. Res. 102A:13-24.
34. Martin, J.B., and J.F. Gusella (1986) Huntington's disease: Pathogenesis and management. N. Engl. J. Med. 315:1267-1276.
35. Martínez-Serrano, A., and A. Björklund (1996) Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J. Neurosci. 16:4604-4616.
36. Mattson, M.P., and B. Cheng (1993) Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis. Stroke 24:136-140.
37. Mattson, M.P., and S.W. Scheff (1994) Endogenous neuroprotection factors and traumatic brain injury: Mechanisms of action and implications for therapy. J. Neurotrauma 11:3-33.
38. Mattson, M.P., B. Cheng, and V.L. Smith-Swintosky (1993) Mechanisms of neurotrophic protection against calcium-and free radical-mediated excitotoxic injury: Implications for treating neurodegenerative disorders. Exp. Neurol. 124:89-95.
39. Paxinos, G., and C. Watson (1986) The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press, pp. 1-236.
40. Rabizadeh, S., J. Oh, L.T. Zhong, J. Yang, C.M. Bitler, L.L. Butcher, and D.E. Bredesen (1993) Induction of apoptosis by the low-affinity NGF receptor. Science 261:345-348.
41. Reynolds, B.A., W. Tetzlaff, and S. Weiss (1992) A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. 12:4565-4574.
42. SAS Institute, Inc. (SAS/STAT users guide, version 6, 4th edition, Vol. 1, SAS Institute Inc., Cary, North Carolina, 1989.
43. Schumacher, J.M., M.P. Short, B.T. Hyman, X.O. Breakefield, and O. Isacson (1991) Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids. Neuroscience 45:561-570.
44. Sobreviela, T., D.O. Clary, L.F. Reichardt, M.M. Brandabur, J.H. Kordower, and E.J. Mufson (1994) TrkA immunoreactive profiles in the central nervous system: Colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J. Comp. Neurol. 350:587-611.
45. Steininger, T.L., B.H. Wainer, R. Klein, M. Barbacid, and H.C. Palfrey (1993) High-affinity nerve growth factor receptor (Trk) immunoreactivity is localized in cholinergic neurons of the basal forebrain and striatum in the adult rat brain. Brain Res. 612:330-335.
46. Venero, J.L., K.D. Beck, and F. Hefti (1994) Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger RNA, but not glutamate decarboxylase messenger RNA. Neuroscience 61:257-268.
47. Vonsattel, J.P., R.J. Ferrante, T.J. Stevens, E.D. Bird, and E.P. Richardson, Jr. (1985) Neuropathologic classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44:559-577.